Sopheon « Terug naar discussie overzicht

Weekdraadje 17 - 2009

53 Posts, Pagina: 1 2 3 » | Laatste
Bertus S
7
I.v.m. de afwezigheid van Frank dit weekend, zal ik voor komende week a.i. het weekdraadje openen en beginnen met deel 2 uit een zesdelige serie van Dr. Carol Pletcher, voormalig Chief Innovation Officer bij Cargill:

Sustaining Innovation in Your Organization – Effective Portfolio Management : Part 2 of 6

Posted by Sopheon in April 17th 2009

Following up with our last discussion about the challenges that face companies in their goal to sustain innovation and continue to move the company forward, we will now discuss how effectively managing your company’s growth portfolio will help to avoid the problems discussed in our last article. A clearly focused company growth portfolio will give the company direction and keep all members of the team in tune, from the company executives, right down to the individual team members.

Growth Portfolio Management

We will first discuss what a growth portfolio should contain. An extensive growth portfolio will contain a number of projects that are aimed at cost reduction, expanding into new markets, new products, and so forth. Having items such as these in your company’s growth portfolio is a great start, but the important thing to keep track of is how well each of these projects are performing in relation to achieving your company’s desired business outcomes.

Carefully selecting which project to pursue at the right moment is what separates the great business managers from the ones that ultimately fail. Choosing the right combination of projects that increase ROI, increase market share, and are ultimately sustainable is the key to successful growth portfolio management.

Keeping your management and team members focused on the execution of the projects in your portfolio is the second piece of the puzzle. Ensuring that your company has a clear view of what the business goals of the company are will allow the individual team members to better understand where they fit into the big picture of things.

Visit us again next week when we discuss how to handle individual challenges to a successful growth campaign for your company: How to Avoid Missing the Mark.

Dr. Carol Pletcher, former Chief Innovation Officer, Cargill, has played an integral part in the company’s new product development process. She was responsible for developing six new product lines aimed at technology roadmapping with special emphasis on new product planning and quality assurance. Dr. Pletcher has been recognized by BusinessWeek.

Bertus S.
[verwijderd]
0
Valt me niet tegen van Bertus,Frank is wel milder in zijn bewoordingen gelukkig alleen maar citaten.
Ben nog altijd voor een eerlijke discussie,maar stangen heb ik een hekel aan.
Weg met de hangjassen op het forum.
[verwijderd]
0
quote:

Bertus S schreef:

I.v.m. de afwezigheid van Frank dit weekend, zal ik voor komende week a.i. het weekdraadje openen en beginnen met deel 2 uit een zesdelige serie van Dr. Carol Pletcher, voormalig Chief Innovation Officer bij Cargill:

Sustaining Innovation in Your Organization – Effective Portfolio Management : Part 2 of 6

Posted by Sopheon in April 17th 2009

Following up with our last discussion about the challenges that face companies in their goal to sustain innovation and continue to move the company forward, we will now discuss how effectively managing your company’s growth portfolio will help to avoid the problems discussed in our last article. A clearly focused company growth portfolio will give the company direction and keep all members of the team in tune, from the company executives, right down to the individual team members.

Growth Portfolio Management

We will first discuss what a growth portfolio should contain. An extensive growth portfolio will contain a number of projects that are aimed at cost reduction, expanding into new markets, new products, and so forth. Having items such as these in your company’s growth portfolio is a great start, but the important thing to keep track of is how well each of these projects are performing in relation to achieving your company’s desired business outcomes.

Carefully selecting which project to pursue at the right moment is what separates the great business managers from the ones that ultimately fail. Choosing the right combination of projects that increase ROI, increase market share, and are ultimately sustainable is the key to successful growth portfolio management.

Keeping your management and team members focused on the execution of the projects in your portfolio is the second piece of the puzzle. Ensuring that your company has a clear view of what the business goals of the company are will allow the individual team members to better understand where they fit into the big picture of things.

Visit us again next week when we discuss how to handle individual challenges to a successful growth campaign for your company: How to Avoid Missing the Mark.

Dr. Carol Pletcher, former Chief Innovation Officer, Cargill, has played an integral part in the company’s new product development process. She was responsible for developing six new product lines aimed at technology roadmapping with special emphasis on new product planning and quality assurance. Dr. Pletcher has been recognized by BusinessWeek.

Bertus S.
Bertus, hou je wel rekening met een "simpele" ?
Maak dit weekdraadje niet te moeilijk .
[verwijderd]
0
quote:

alfahenkie schreef:

Bertus, hou je wel rekening met een "simpele" ?
Maak dit weekdraadje niet te moeilijk .
Ja Bertus niet al te moeilijk maken voor al die simpele zielen,als ze het niet snappen lopen ze misschien wel weg ,en wat moet je dan met je sopheon ?
Bertus S
0
quote:

alfahenkie schreef:

Bertus, hou je wel rekening met een "simpele" ?
Maak dit weekdraadje niet te moeilijk .
Nee Henk, houd geen rekening met wélke "simpele ziel" danook en mochten ze daarom weglopen, graag zelfs, zou ik willen zeggen.

En daarbij, zó moeilijk zijn de draadjes meestal niet.

Bertus S.
Arie de Beuker
0
quote:

Dezoeker schreef:

[quote=alfahenkie]
Bertus, hou je wel rekening met een "simpele" ?
Maak dit weekdraadje niet te moeilijk .
[/quote]

Ja Bertus niet al te moeilijk maken voor al die simpele zielen,als ze het niet snappen lopen ze misschien wel weg ,en wat moet je dan met je sopheon ?
Is voor de domme onderons, zoals ik, ook makkelijker.
Iedereen nog bedankt voor het plaatsen van goede info afgelopen weken.
gr
Arie de Beuker

[verwijderd]
0
Ha Bertus,

Bedankt. Toppie.

Ik had van afgelopen week nog een paar berichten van jou die je geplaatst had, doe ik er nu maar gelijk even bij.

Bertus S - 12 apr 09, 11:51
| Reageer | Quote | Zoek | Dit is niet OK | Aanbevolen: 0

Aligning People, Process, And Technology To Drive Product And Technology Innovation Performance

Presented by Wally Slone, Vice President Business Solutions

Thursday, April 23, 2009

Webinar cost: Free
Duration: 1 hour
Start Time: 4:00 pm GMT - 11:00 am Eastern - 8:00 am Pacific

For Fresenius Medical Care, developing high-quality products effectively and proficiently is a mission-critical business process. When the $10 billion market leader in life-sustaining dialysis products and services sought to enhance its innovation efforts, the strategy included implementing a disciplined Stage-Gate® process. The initial goal was to establish new levels of process efficiency and consistency that would increase speed-to-market and sustain the existing product portfolio.

Mr. Slone led his organization’s effort to implement more productive Product Lifecycle Management. His team focused on understanding the current reality of product innovation by first engaging the people who would ultimately be the process’ end-users. This set the foundation for change. Fresenius has subsequently transformed its product ideation-to-launch process. By killing less attractive projects and shifting valuable resources, Mr. Slone and his team have reinvigorated a focus on critical projects, accelerating time-to-market without reducing the value of the organization’s pipeline.

By attending this free, online event you will learn:

How Fresenius modeled and leveraged a powerful combination of people, process, and technology to raise the level of new-product innovation results
How stakeholders were engaged to ensure that the organization’s new innovation process was adopted and supported sought-after performance goals
How the Stage-Gate® process helped Fresenius change its organization into a business-minded culture
*Stage-Gate® is a registered trademark of the Product Development Institute

Wally Slone is Vice President of Business Solutions for the Renal Therapies Group of Fresenius Medical Care. Mr. Sloan is responsible for the Group’s business systems, program management and information technology. He also oversees the organization’s innovation programs, including Stage-Gate®, portfolio management, culture transformation and technology initiatives, helping drive the Group’s achievement of its strategic goals.

Bertus S - 15 apr 09, 19:28
| Reageer | Quote | Zoek | Dit is niet OK | Aanbevolen: 0

Sustaining Innovation in Your Organization – Strategic Alignment: Part 1 of 6

Posted by sopheon in April 15th 2009

www.iex.nl/forum/topic.asp?forum=126&...

[verwijderd]
0
Aangezien we de 7e Mei weer een PB krijgen zal er wellicht ook wel weer een stand van zaken gegeven worden tot en met de 6e.
Gaan we hier zelf nog een bedrag aangeven wat we verwachtten de 7e? Is verder toch niets te doen.

In Maart was het 5.4.
Ik ga voor: 6.5.
Bertus S
0
[verwijderd]
0
[verwijderd]
0
Sorry Frank
Ik doen niet meer met een voorspelling mee..
Heeft in mijn ogen ook totaal geen nut en helpt mede om verwachten op te kloppen of juist niet..
Ik wacht gewoon en kijk wel wat het wordt..
(niet negatief bedoeld dat weet je he..just my opinion
Groeten
Lion
[verwijderd]
0
Bertus S
0
Sustaining Innovation in Your Organization – How to Handle Missing the Mark: Part 3 of 6

Posted by Sopheon in April 20th 2009

So now that you have your growth portfolio set up, you sit back, close your eyes and begin to envision the profits that your company will be enjoying. Shortly after the launch of your campaign, the figures come back to your desk and you realize that you have “missed the mark.” Your entire campaign, has failed to provide significant growth and profits and grumblings begin from below about all the unnecessary time spent on this portfolio.

How to Avoid Missing the Mark

Missing the mark can happen at a variety of points, from the IT Department to the Marketing Department. It is often easy to see that a product campaign has missed the mark, but identifying the location of the bottleneck can be a more difficult task. Determining where the bottleneck in innovation occurs is the first step in effective innovation management.

Ignorance is often the main factor behind a marketing campaign that has missed the mark. The target markets may have been inaccurately pin-pointed, the actual product might not be efficient or effective in the eyes of the target consumer, or a variety of other circumstances. It is important to get accurate data regarding the effectiveness of your campaign as soon as possible, so you can determine just how on target you were with your efforts.

While it may be difficult to change strategies mid campaign, you might be able to minimize losses and redirect efforts to more effective markets. Whether you change your target market, advertising focus, or marketing efforts on a different demographic, lower price to change your position on the value chain, or offer a different set of services to accompany your product, something must be done to increase your market presence and profit margins.

Missing the mark is a major problem, but one that can be remedied with prompt and accurate information regarding the effectiveness of the campaign. Next week we will delve into the proper management techniques to get the most out of your potential project’s ROI with the article Manage Your Rollouts Effectively.

Former Chief Innovation Officer at Cargill, Dr. Carol Pletcher, was a key contributor to the company’s efforts to enhance innovation management. She was responsible for developing six new product lines aimed at roadmap development with special emphasis on new product planning, food safety and quality assurance. Dr. Pletcher has been recognized by BusinessWeek

Bertus S.
53 Posts, Pagina: 1 2 3 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
796,45  0,00  0,00%  09 apr
 Germany40^ 21.199,30 +7,77%
 BEL 20 3.862,22 0,00%
 Europe50^ 4.977,14 +7,68%
 US30^ 40.567,70 -0,19%
 Nasd100^ 19.000,80 -0,72%
 US500^ 5.433,55 -0,37%
 Japan225^ 34.467,40 -1,03%
 Gold spot 3.123,02 +1,30%
 EUR/USD 1,0987 +0,31%
 WTI 62,52 0,00%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

AALBERTS NV 0,00%
ABN AMRO BANK... 0,00%
Accsys 0,00%
ACOMO 0,00%
ADYEN NV 0,00%

Dalers

AALBERTS NV 0,00%
ABN AMRO BANK... 0,00%
Accsys 0,00%
ACOMO 0,00%
ADYEN NV 0,00%